Welcome to Ligand Pharmaceuticals

Ligand is a high-growth company with economic rights to some of the world's most important medicines.

Portfolio
Technologies
Licensing Opportunities

Latest News

Ligand to Host Investor and Analyst Day on December 12, 2023 in New York City

Read More

Ligand Reports Third Quarter 2023 Financial Results

Read More

Ligand Acquires Royalty on Sanofi’s TZIELD® for $20 Million

Read More

Recent Events

Upcoming Events

Stock Snapshot

LGND
Nasdaq
Volume
Market Cap
Day Range
52-Week Range